Combinatorial Immunotherapy: PD-1 may not be LAG-ing behind any more

por Turnis, Meghan E., Korman, Alan J., Drake, Charles G., Vignali, Dario A.A.
Publicado 2012

Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti–CTLA-4 antibodies

por Peggs, Karl S., Quezada, Sergio A., Chambers, Cynthia A., Korman, Alan J., Allison, James P.
Publicado 2009

Workshop on immunotherapy combinations. Society for immunotherapy of cancer annual meeting Bethesda, November 3, 2011

por Forero, Ivan Martinez, Okada, Hideho, Topalian, Suzanne L, Gajewski, Thomas F, Korman, Alan J, Melero, Ignacio
Publicado 2012

An open-label, multiple ascending dose study of the anti-CTLA-4 antibody ipilimumab in viremic HIV patients

por Colston, Elizabeth, Grasela, Dennis, Gardiner, David, Bucy, R. Pat, Vakkalagadda, Blisse, Korman, Alan J., Lowy, Israel
Publicado 2018

Activation of innate and adaptive immunity as an effective combined strategy for cancer immunotherapy

por Rakhmilevich, Alexander, Felder, Mildred, Lever, Lauren, Van De Voort, Tyler, Korman, Alan J, Gillies, Stephen D, Sondel, Paul M
Publicado 2015

Preclinical Characterization of Relatlimab, a Human LAG-3–Blocking Antibody, Alone or in Combination with Nivolumab

por Thudium, Kent, Selby, Mark, Zorn, Julie A., Rak, Gregory, Wang, Xi-Tao, Bunch, Roderick Todd, Hogan, Jason M., Strop, Pavel, Korman, Alan J.
Publicado 2022

Blockade ofthe negative co-stimulatory molecules PD-1 and CTLA-4 improves survival in primary and secondary fungal sepsis

por Chang, Katherine C, Burnham, Carey-Ann, Compton, Stephanie M, Rasche, David P, Mazuski, RichardJ, SMcDonough, Jacquelyn, Unsinger, Jacqueline, Korman, Alan J, Green, Jonathan M, Hotchkiss, Richard S
Publicado 2013

Serum immunoregulatory proteins as predictors of overall survival of metastatic melanoma patients treated with ipilimumab

por Koguchi, Yoshinobu, Hoen, Helena, Bambina, Shelly, Rynning, Michael, Fuerstenberg, Richard, Feng, Zipei, Fox, Bernard, Bifulco, Carlo, Curti, Brendan D, Urba, Walter, Milburn, Christina, Korman, Alan J, Bahjat, Keith S
Publicado 2015

Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma

por Wolchok, Jedd D, Hodi, F Stephen, Weber, Jeffrey S, Allison, James P, Urba, Walter J, Robert, Caroline, O'Day, Steven J, Hoos, Axel, Humphrey, Rachel, Berman, David M, Lonberg, Nils, Korman, Alan J
Publicado 2013

Immunocytokine augments local and abscopal response and animal survival when added to radiation and CTLA-4 checkpoint inhibition in a murine melanoma model

por Morris, Zachary S, Guy, Emily I, Francis, David M, Gressett, Monica M, Armstrong, Eric A, Huang, Shyhmin, Gillies, Stephen D, Korman, Alan J, Hank, Jacquelyn A, Rakhmilevich, Alexander L, Harari, Paul M, Sondel, Paul M
Publicado 2015

Preclinical Development of Ipilimumab and Nivolumab Combination Immunotherapy: Mouse Tumor Models, In Vitro Functional Studies, and Cynomolgus Macaque Toxicology

por Selby, Mark J., Engelhardt, John J., Johnston, Robert J., Lu, Li-Sheng, Han, Minhua, Thudium, Kent, Yao, Dapeng, Quigley, Michael, Valle, Jose, Wang, Changyu, Chen, Bing, Cardarelli, Pina M., Blanset, Diann, Korman, Alan J.
Publicado 2016

Correction: Preclinical Development of Ipilimumab and Nivolumab Combination Immunotherapy: Mouse Tumor Models, In Vitro Functional Studies, and Cynomolgus Macaque Toxicology

por Selby, Mark J., Engelhardt, John J., Johnston, Robert J., Lu, Li-Sheng, Han, Minhua, Thudium, Kent, Yao, Dapeng, Quigley, Michael, Valle, Jose, Wang, Changyu, Chen, Bing, Cardarelli, Pina M., Blanset, Diann, Korman, Alan J.
Publicado 2016

Complimentary mechanisms of dual checkpoint blockade expand unique T-cell repertoires and activate adaptive anti-tumor immunity in triple-negative breast tumors

por Crosby, Erika J., Wei, Junping, Yang, Xiao Yi, Lei, Gangjun, Wang, Tao, Liu, Cong-Xiao, Agarwal, Pankaj, Korman, Alan J., Morse, Michael A., Gouin, Kenneth, Knott, Simon R. V., Lyerly, H. Kim, Hartman, Zachary C.
Publicado 2018

Interleukin-21 combined with PD-1 or CTLA-4 blockade enhances antitumor immunity in mouse tumor models

por Lewis, Katherine E., Selby, Mark J., Masters, Gregg, Valle, Jose, Dito, Gennaro, Curtis, Wendy R., Garcia, Richard, Mink, Kathy A., Waggie, Kimberly S., Holdren, Matthew S., Grosso, Joseph F., Korman, Alan J., Jure-Kunkel, Maria, Dillon, Stacey R.
Publicado 2017

Combining Intra-Tumoral Treg Depletion with Androgen Deprivation Therapy (ADT): Pre-Clinical Activity in the Myc-CaP Model

por Shen, Ying-Chun, Ghasemzadeh, Ali, Kochel, Christina M., Nirschl, Thomas R., Francica, Brian J., Lopez-Bujanda, Zoila A., Carrera Haro, Maria A., Tam, Ada, Anders, Robert A., Selby, Mark J., Korman, Alan J., Drake, Charles G.
Publicado 2017

TIGIT blockade enhances functionality of peritoneal NK cells with altered expression of DNAM-1/TIGIT/CD96 checkpoint molecules in ovarian cancer

por Maas, Ralph Ja, Hoogstad-van Evert, Janneke S, Van der Meer, Jolien Mr, Mekers, Vera, Rezaeifard, Somayeh, Korman, Alan J, de Jonge, Paul Kjd, Cany, Jeannette, Woestenenk, Rob, Schaap, Nicolaas Pm, Massuger, Leon F, Jansen, Joop H, Hobo, Willemijn, Dolstra, Harry
Publicado 2020

A Randomized, Double-Blind, Placebo-Controlled Assessment of BMS-936558, a Fully Human Monoclonal Antibody to Programmed Death-1 (PD-1), in Patients with Chronic Hepatitis C Virus...

por Gardiner, David, Lalezari, Jay, Lawitz, Eric, DiMicco, Michael, Ghalib, Rheem, Reddy, K. Rajender, Chang, Kyong-Mi, Sulkowski, Mark, Marro, Steven O’, Anderson, Jeffrey, He, Bing, Kansra, Vikram, McPhee, Fiona, Wind-Rotolo, Megan, Grasela, Dennis, Selby, Mark, Korman, Alan J., Lowy, Israel
Publicado 2013

Blood–brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapy

por Galstyan, Anna, Markman, Janet L., Shatalova, Ekaterina S., Chiechi, Antonella, Korman, Alan J., Patil, Rameshwar, Klymyshyn, Dmytro, Tourtellotte, Warren G., Israel, Liron L., Braubach, Oliver, Ljubimov, Vladimir A., Mashouf, Leila A., Ramesh, Arshia, Grodzinski, Zachary B., Penichet, Manuel L., Black, Keith L., Holler, Eggehard, Sun, Tao, Ding, Hui, Ljubimov, Alexander V., Ljubimova, Julia Y.
Publicado 2019

Author Correction: Blood–brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapy

por Galstyan, Anna, Markman, Janet L., Shatalova, Ekaterina S., Chiechi, Antonella, Korman, Alan J., Patil, Rameshwar, Klymyshyn, Dmytro, Tourtellotte, Warren G., Israel, Liron L., Braubach, Oliver, Ljubimov, Vladimir A., Mashouf, Leila A., Ramesh, Arshia, Grodzinski, Zachary B., Penichet, Manuel L., Black, Keith L., Holler, Eggehard, Sun, Tao, Ding, Hui, Ljubimov, Alexander V., Ljubimova, Julia Y.
Publicado 2020

Author Correction: Blood–brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapy

por Galstyan, Anna, Markman, Janet L., Shatalova, Ekaterina S., Chiechi, Antonella, Korman, Alan J., Patil, Rameshwar, Klymyshyn, Dmytro, Tourtellotte, Warren G., Israel, Liron L., Braubach, Oliver, Ljubimov, Vladimir A., Mashouf, Leila A., Ramesh, Arshia, Grodzinski, Zachary B., Penichet, Manuel L., Black, Keith L., Holler, Eggehard, Sun, Tao, Ding, Hui, Ljubimov, Alexander V., Ljubimova, Julia Y.
Publicado 2020